Plain-English translation of NCT07102030 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at Karolinska in Stockholm are studying lupus by collecting detailed health information, blood and urine samples, and lifestyle questionnaires from lupus patients over many years. This long-term project helps doctors understand why lupus affects different people differently and how to personalize treatment. The study has been running since the mid-1990s and is still enrolling new patients.
Lupus is a complex disease that looks and behaves differently in each person, making treatment challenging. By gathering detailed information from many patients over time, researchers hope to identify distinct subtypes of lupus and develop better, more targeted treatment strategies for each type.
You likely qualify if…
You likely don't qualify if…
You would visit the rheumatology clinic for a detailed health assessment, answer questions about your lifestyle and disease symptoms, and have blood, urine, and saliva samples collected. You may also have imaging tests like ultrasound or bone density scans. Your participation is part of ongoing research, so you may be invited for follow-up visits over many years to track how your lupus evolves.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Sweden
Karolinska Institutet, National Institutes of Health (NIH)
Enrollment target
~900 participants
Started
February 2015
Primary completion
December 2029
Age range
18 Years – 100 Years
Last updated on clinicaltrials.gov in August 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Elisabet Svenungsson, MD, PhD
Region Stockholm
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.